Related Experiment Video

Updated: Jun 5, 2025

Glycemic Impact on Knee Osteoarthritis Symptoms on Physical, Radiographic, and Inflammatory Markers among Individuals Aged 50 and Over with Diabetes
07:22

Glycemic Impact on Knee Osteoarthritis Symptoms on Physical, Radiographic, and Inflammatory Markers among Individuals Aged 50 and Over with Diabetes

Published on: March 7, 2025

197

Parental Psychosocial Variables and Glycemic Control in T1D Pediatric Age: A Systematic Review

Vasco Costa1, Bárbara Pereira2, Susana R Patton3

  • 1William James Center for Research, Ispa-Instituto Universitário, Lisboa, Portugal. 26054@alunos.ispa.pt.

Current Diabetes Reports
|December 16, 2024
PubMed

Insights

Parental psychosocial factors like stress and fear of hypoglycemia significantly impact glycemic control in children with Type 1 Diabetes (T1D). Interventions targeting parental well-being are crucial for improving child health outcomes.

Area of Science:

  • Pediatric Endocrinology
  • Psychosocial Health
  • Diabetes Management

Background:

  • Managing Type 1 Diabetes (T1D) in young children presents significant challenges for parents.
  • Parental psychological adjustment is intrinsically linked to pediatric glycemic outcomes.
  • Existing research highlights the complexity of the parent-child dynamic in T1D care.

Purpose of the Study:

  • To systematically review and synthesize evidence on the association between parental psychosocial factors and glycemic outcomes in children aged 1-10 years.
  • To identify key parental psychosocial variables influencing glycemic control in pediatric T1D.
  • To summarize current findings on the relationship between parental stress, fear of hypoglycemia, family conflict, and child's HbA1c levels.

Main Methods:

  • Systematic literature review conducted following PRISMA guidelines.
  • Searches performed across four major databases between 2019 and 2024.
  • Inclusion criteria focused on studies examining parental psychosocial factors and glycemic outcomes in children aged 1-10 years with T1D.

Main Results:

  • Five studies were included in the final analysis, identifying direct associations between parental psychosocial variables and children's glycemic outcomes.
  • Findings suggest a predominantly unidirectional influence of parental factors on child glycemic control.
  • Specific parental psychosocial variables explored included fear of hypoglycemia, stress, and family conflict.

Conclusions:

  • Parental psychosocial well-being is a critical determinant of glycemic outcomes in children with T1D.
  • There is a need for further research to explore the longitudinal interplay between parental factors and child glycemic control.
  • Implementing parental psychological interventions may be essential for optimizing glycemic management and improving health outcomes in pediatric T1D.
Abstract

Keywords:
Children Glycemic ControlParental Psychosocial VariablesPediatric AgeType 1 Diabetes

More Related Videos

A High-Throughput Multiplexed Screening for Type 1 Diabetes, Celiac Diseases, and COVID-1906:46

A High-Throughput Multiplexed Screening for Type 1 Diabetes, Celiac Diseases, and COVID-19

Published on: July 5, 2022

2.7K
Improving IV Insulin Administration in a Community Hospital12:08

Improving IV Insulin Administration in a Community Hospital

Published on: June 11, 2012

18.8K

Related Concept Videos

Diabetes Mellitus: Type 2 and Gestational01:22

Diabetes Mellitus: Type 2 and Gestational

Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
2.2K
Pathophysiology of Diabetes01:20

Pathophysiology of Diabetes

Diabetes mellitus is a chronic metabolic disorder characterized by hyperglycemia. The four categories of diabetes are type 1 diabetes, type 2 diabetes, other specific types of diabetes, and gestational diabetes.
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...
862
Diabetes Mellitus: Overview and Type I Subtype01:22

Diabetes Mellitus: Overview and Type I Subtype

Diabetes mellitus is a chronic metabolic disorder characterized by high blood glucose levels due to inadequate insulin production, insulin resistance, or both. The condition affects millions worldwide and can significantly impact their health and quality of life.
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
2.4K
Diabetes: Management and Pharmacotherapy01:15

Diabetes: Management and Pharmacotherapy

The therapy for diabetes aims to alleviate hyperglycemia-related symptoms, prevent acute metabolic decompensation, and reduce chronic end-organ complications. Glycemic control is evaluated through short-term (self-monitoring, continuous glucose monitoring) and long-term (A1c, fructosamine) metrics, enabling near real-time tracking of blood glucose levels and reflecting glycemic control over specific time frames.
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
234
Diabetes: Symptoms, Diagnosis, and Complications01:15

Diabetes: Symptoms, Diagnosis, and Complications

For most patients, experiencing several weeks of polyuria, polydipsia, fatigue, and significant weight loss may indicate the presence of diabetes. Furthermore, adults displaying the phenotypic appearance of type 2 diabetes (particularly those who are obese and not initially insulin-requiring), may have islet cell autoantibodies, suggesting autoimmune-mediated β cell destruction and a diagnosis of latent autoimmune diabetes of adults (LADA). The categorization of glucose homeostasis is...
503
Insulin: Dosing Regimen and Adverse Effects01:16

Insulin: Dosing Regimen and Adverse Effects

Insulin-replacement therapy usually includes both long-acting insulin (basal) and short-acting insulin (to cater to postprandial needs). In a diverse group of type 1 diabetes patients, the average daily insulin dose is typically 0.5-0.7 units/kg body weight. However, obese patients and pubertal adolescents may need more due to insulin resistance.
The basal dose constitutes about 40%-50% of the total daily dose, with the rest as premeal insulin. The mealtime insulin dose should mirror...
142